Articles

Videos

Podcasts

Clinical

Specialty medications should not be defined by their cost and should instead be defined by their efficacy. 

How Do We Pay for Specialty Pharmacy?

Susan Lang, MA, MBA, the CEO of XIL Health and former senior executive with Express Grips, discusses what might happen to independent pharmacies if things continue as they are following the financial difficulties of the pandemic.

Expert: Financial Burdens on Small Chains, Independent Pharmacies Are Creating Pharmacy Deserts

Susan Lang, MA, MBA, the CEO of XIL Health, discusses how pharmacies that have already been hard hit by the pandemic may be impacted if Pfizer goes through with their projected increased in COVID-19 vaccine prices.

Assessing How Increases in COVID-19 Vaccine Prices May Impact Pharmacies

Michael Holden, FRPharmS, FRSPH, associate director of Pharmacy Complete in the United Kingdom, discusses some of the key differences between the role of the pharmacist in the United Kingdom versus the United States.

Expert: Pharmacy Globally Must Value Itself for Providing ‘Not Just a Packet of Pills, But a Package of Care’

Catherine Duggan, FRPharmS, CEO of International Pharmaceutical Federation, discusses the role and the authorities of the pharmacist internationally, and the effect the pandemic has had on that role globally.

Expert: Pharmacy Has Been a ‘Beacon in Communities Across the World’ During the Pandemic

Susan Lang, CEO of XIL Health and former senior executive at Express Scripts, discusses some of the reimbursement issues that have been arising for pharmacies while administering COVID-19 vaccines.

Understanding the Reimbursement Issues for Pharmacies Around COVID-19 Vaccines

Susan Lang, CEO of XIL Health and former senior executive at Express Scripts, discusses the impact of declining reimbursements on pharmacies that were already hard hit by the COVID-19 pandemic.

With Declining Reimbursements, Community Pharmacies Have Been Hit Hard by the Pandemic

High engagement and collaboration between health systems and health plans is essential to implementing value-based models, according to a session at the Pharmacy Quality Alliance 2021 Annual Conference.

Pharmacist Integration is Essential to Implementing Value-Based Care Models

Policy changes impacting the star ratings for 2022 include additional flexibility provided during the COVID-19 pandemic and a revised Extreme and Uncontrollable Circumstances policy.

Experts Say COVID-19 Pandemic Will Have Lasting Impact on CMS Star Ratings

Further integration with care teams and using data to demonstrate the value of pharmacists will be essential to maintaining the momentum created by the COVID-19 pandemic.